MHRA Drug Safety Update: January 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 6 January 2024) has been published and includes articles on:

  • Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory  measures in men and women under 55 years of age
  • Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
  • Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or  cardiovascular risk factors
  • Letters and medicine recalls sent to healthcare professionals in December 2023.

To see the latest MHRA Drug Safety Updates in full, visit the website.